Nucleon Therapeutics LLP - travel and hospitality in Mumbai, Maharashtra, India. Directors, charges & compliance details.
LLPIN AAJ-2427 Incorporated 24 April 2017 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Limited Liability Partnership travel and hospitality
Data last updated
Contribution obligation
₹1 Lakh
As per LLP agreement
LLP age
9 yrs
Est. 2017
Designated partners
2
As per MCA filings
GST registrations
2
None active
Last financials
Mar 2023
Balance sheet date
LLP status
Active
MCA master data
Registrar
Mumbai
ROC office
Incorporated
24 Apr 2017
Date of incorporation

About Nucleon Therapeutics LLP

Data last updated:

Nucleon Therapeutics LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India. It operates in the consumer and professional services segment of the travel and hospitality sector. It was incorporated on 24 April 2017 and has been in existence for over 9 years.

The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAJ-2427. The LLP has 2 GST registrations on record, none of which is active.

The LLP has a total obligation of contribution of β‚Ή1 Lakh. It is led by designated partners Rashmi Santosh Mahadik and Anushka Vilas Salvi.

Its latest statement of accounts is for the year ended 31 March 2023. The registered office is at Office 204/205 So Lucky Corner Coop Soc Opp. Holy Family Church Andheri East, Mumbai, Maharashtra, India – 400099.

Company details

LLPIN AAJ-2427
Incorporation Date 24 April 2017
Total Obligation of Contribution β‚Ή1 Lakh
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 March 2023
Date of Balance Sheet 31 March 2023

Contact details

Nucleon Therapeutics LLP's registered office is in Mumbai, Maharashtra.

  • Registered Address
    Office 204/205 So Lucky Corner Coop Soc Opp. Holy Family Church Andheri East, Mumbai, Maharashtra, India – 400099
  • Industry
    Travel and Hospitality, Consumer Professional Services
Comprehensive company report
Nucleon Therapeutics LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout Β· GST invoice included

Financials of Nucleon Therapeutics LLP

FY 2023 filings available

Financial Statement Summary

Statement of Account and SolvencyFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Income and Expenditure
Turnover
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
Net Profit Margin
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Nucleon Therapeutics LLP, buy the company report.

Designated partners of Nucleon Therapeutics LLP

Nucleon Therapeutics has 2 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Rashmi Santosh MahadikDesignated Partner30 Mar 20197 Years 6 MonthsCurrent
Anushka Vilas SalviDesignated Partner20 Aug 20197 Years 2 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Nucleon Therapeutics LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Nucleon Therapeutics has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.

Total GSTINs
2
Cancelled / inactive
2

To see the full GST registrations and return filing status of Nucleon Therapeutics LLP, buy the company report.

Recent activity

Nucleon Therapeutics LLP has 4 designated partner changes on record since 2019: 2 appointments and 2 cessations. The latest: Anushka Vilas Salvi was appointed as Designated Partner on 20 Aug 2019.

AGM
Nucleon Therapeutics Llp last Annual general meeting of members was held on 31 Mar 2023 as per latest MCA records.
Filing
Nucleon Therapeutics Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai I.
Appointed
Anushka Vilas Salvi was appointed as Designated Partner.
Ceased
Ujwala Vilas Salvi ceased to be Designated Partner.
Appointed
Rashmi Santosh Mahadik was appointed as Designated Partner.
Ceased
Vilas Maruti Salvi ceased to be Designated Partner.
Incorporation
24 Apr 2017
Nucleon Therapeutics Llp was registered on 24 Apr 2017 with Roc Mumbai I & aged 9 years 6 months as per MCA records.

Frequently asked questions

Nucleon Therapeutics is an active limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in consumer professional services, within the travel and hospitality industry. It was incorporated on 24 April 2017 (9+ years old) and is registered under LLPIN AAJ-2427.

Nucleon Therapeutics has 2 current designated partners:

The latest financial statements of Nucleon Therapeutics on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 31 March 2023. Year-wise statements from FY 2018 are in the company report.

No. Nucleon Therapeutics has 2 GST registrations on record and all of them are cancelled or inactive.

The LLPIN (Limited Liability Partnership Identification Number) of Nucleon Therapeutics is AAJ-2427. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Nucleon Therapeutics was incorporated on 24 April 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.

Anushka Vilas Salvi was appointed as Designated Partner on 20 Aug 2019. Ujwala Vilas Salvi ceased to be Designated Partner on 20 Aug 2019. Rashmi Santosh Mahadik was appointed as Designated Partner on 30 Mar 2019. Nucleon Therapeutics has 4 designated partner changes on record in total.

The registered office of Nucleon Therapeutics is at Office 204205 So Lucky Corner Coop Soc Opp. Holy Family Church Andheri East, Mumbai, Maharashtra, India – 400099.

Nucleon Therapeutics operates in the travel and hospitality industry, in the consumer professional services segment.

Nucleon Therapeutics can be reached at its registered office: Office 204205 So Lucky Corner Coop Soc Opp. Holy Family Church Andheri East, Mumbai, Maharashtra, India – 400099.